Recommendation ID
IPG539/1
Question

NICE encourages further research into radiofrequency ablation for symptomatic Morton's neuroma. Further research should include details of patient selection and previous treatments. Studies should compare the procedure against other non-surgical treatments, such as steroid injections.
Outcome measures should include pain relief, the duration of treatment effect, and the need for subsequent treatments.

Any explanatory notes
(if applicable)

Current evidence on radiofrequency ablation for symptomatic interdigital (Morton's) neuroma raises no major safety concerns. The evidence on efficacy is limited in quantity and quality. Therefore, this procedure should only be used with special arrangements for clinical governance, consent and audit or research.


Source guidance details

Comes from guidance
Radiofrequency ablation for symptomatic interdigital (Morton’s) neuroma
Number
IPG539
Date issued
December 2015

Other details

Is this a recommendation for the use of a technology only in the context of research? Yes  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 31/12/2015